Large-scale falsification of research papers risks public trust in biomedical sciences.

Rory Bricker-Anthony, Roland W Herzog
Author Information
  1. Rory Bricker-Anthony: Scientific Editor, Molecular Therapy family of journals, American Society of Gene & Cell Therapy.
  2. Roland W Herzog: Editor-in-Chief, Molecular Therapy; Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University, Bloomington, IN, USA. Electronic address: rwherzog@iu.edu.

Abstract

No abstract text available.

References

  1. Mol Ther. 2023 Dec 6;31(12):3376-3388 [PMID: 37927037]
  2. Mol Ther Nucleic Acids. 2022 Dec 01;30:595 [PMID: 36514355]
  3. Mol Ther. 2021 Sep 15;: [PMID: 34534693]
  4. Mol Ther. 2021 Mar 3;29(3):889-890 [PMID: 33581045]
  5. Mol Ther. 2022 Jul 6;30(7):2390 [PMID: 35709762]
  6. Mol Ther. 2023 Jun 7;31(6):1503-1504 [PMID: 37236186]
  7. Science. 2023 Aug 11;381(6658):587 [PMID: 37561847]
  8. Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar;394(3):431-436 [PMID: 33547901]
  9. Br J Cancer. 2020 Sep;123(7):1131-1144 [PMID: 32606358]
  10. Biomark Insights. 2019 Feb 05;14:1177271919829162 [PMID: 30783377]
  11. Cell Death Dis. 2021 Jul 29;12(8):749 [PMID: 34321458]
  12. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):5049-5066 [PMID: 38194106]
  13. Mol Ther. 2024 Mar 6;32(3):852 [PMID: 38458697]
  14. Nucleic Acids Res. 2022 Nov 28;50(21):12058-12070 [PMID: 36477580]

MeSH Term

Trust
Biomedical Research

Word Cloud

Created with Highcharts 10.0.0Large-scalefalsificationresearchpapersriskspublictrustbiomedicalsciences

Similar Articles

Cited By

No available data.